Warning: Declaration of Jetpack_IXR_Client::query() should be compatible with IXR_Client::query(...$args) in /home/iau/public_html/aydindental.aydin.edu.tr/wp-content/plugins/jetpack/vendor/automattic/jetpack-connection/legacy/class-jetpack-ixr-client.php on line 122
{"id":228,"date":"2020-02-18T13:59:20","date_gmt":"2020-02-18T10:59:20","guid":{"rendered":"http:\/\/10.15.0.91:8080\/?page_id=228"},"modified":"2026-04-09T10:07:40","modified_gmt":"2026-04-09T07:07:40","slug":"yazim-klavuzu","status":"publish","type":"page","link":"https:\/\/aydindental.aydin.edu.tr\/tr\/yazim-klavuzu\/","title":{"rendered":"Yaz\u0131m Kurallar\u0131"},"content":{"rendered":"

Makale Dili ve Bi\u00e7imsel \u00d6zellikler<\/strong><\/li>\n<\/ol>\n
\n
Makaleler T\u00fcrk\u00e7e veya \u0130ngilizce dillerinde kabul edilmektedir.<\/li>\n
Sayfa yap\u0131s\u0131: T\u00fcm kenarlardan 2.5 cm bo\u015fluk b\u0131rak\u0131lmal\u0131d\u0131r.<\/li>\n
Yaz\u0131 tipi: Times New Roman; 11 punto, 1.15 sat\u0131r aral\u0131\u011f\u0131.<\/li>\n
Paragraflar iki yana yasl\u0131 olmal\u0131 ve Word paragraf ayarlar\u0131ndan \u201cParagraftan sonra bo\u015fluk ekle\u201d se\u00e7ene\u011fi kullan\u0131larak d\u00fczenlenmelidir. Elle bo\u015f sat\u0131r eklenmemelidir.<\/li>\n
Paragraflarda girinti (paragraf ba\u015f\u0131) yap\u0131lmamal\u0131d\u0131r.<\/li>\n
Sat\u0131r numaralar\u0131: \u00d6zet\/Abstract b\u00f6l\u00fcm\u00fc hari\u00e7 olmak \u00fczere, ana metnin t\u00fcm sat\u0131rlar\u0131na sat\u0131r numaras\u0131 eklenmelidir.<\/li>\n
K\u0131saltmalar: Ana metinde ilk ge\u00e7ti\u011fi yerde a\u00e7\u0131k hali verilerek tan\u0131mlanmal\u0131, parantez i\u00e7inde k\u0131saltmas\u0131 belirtilmeli, sonraki kullan\u0131mlarda sadece k\u0131saltma kullan\u0131lmal\u0131d\u0131r.<\/li>\n
T\u00fcm yaz\u0131lar siyah renkte yaz\u0131lmal\u0131d\u0131r.<\/li>\n
T\u00fcm ba\u015fl\u0131klarda sadece kelimelerinin ilk harfi b\u00fcy\u00fck olmal\u0131d\u0131r. (ABSTRACT ve \u00d6ZET ba\u015fl\u0131klar\u0131 hari\u00e7)<\/li>\n
Tam metin ve ba\u015fl\u0131k dosyan\u0131zdaki t\u00fcm ba\u015fl\u0131klar kal\u0131n punto ile yaz\u0131lmal\u0131d\u0131r. (tablo ve \u015fekillerde sadece say\u0131 belirten ba\u015fl\u0131k kal\u0131n punto ile yaz\u0131lmal\u0131d\u0131r. (\u00d6rn: Table 3.\u00a0<\/strong>Aaaaaaa)<\/li>\n<\/ul>\n
\n
Dosya Y\u00fckleme Kurallar\u0131<\/strong><\/li>\n<\/ol>\n
\n
“Tam Metin” ba\u015fl\u0131\u011f\u0131 alt\u0131nda, \u00f6zet, abstract, ana metin, kaynak\u00e7a, tablo ve \u015fekilleri i\u00e7eren tek bir Word dosyas\u0131 olarak sisteme y\u00fcklenmelidir.<\/li>\n
Ayr\u0131ca a\u015fa\u011f\u0131da listelenen t\u00fcm bile\u015fenler,ilgili ba\u015fl\u0131klar alt\u0131nda ayr\u0131 ayr\u0131 dosyalar halinde<\/strong>\u00a0sisteme y\u00fcklenmelidir:\n
\n
Kapak Sayfas\u0131<\/li>\n
Tam Metin<\/li>\n
\u015eekil ve Tablolar<\/li>\n
Benzerlik Raporu<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n
Etik Onay\/Hasta Onam\u0131<\/p>\n
\n
\n
\n
Telif Hakk\u0131 Formu<\/li>\n
\u00c7\u0131kar \u00c7at\u0131\u015fmas\u0131 Formu<\/li>\n
Yazar Katk\u0131 Formu<\/li>\n<\/ul>\n<\/li>\n
Y\u00fcklenen her dosyan\u0131n ad\u0131, sisteme y\u00fcklenirken se\u00e7ilen dosya t\u00fcr\u00fcyle birebir uyumlu olmal\u0131d\u0131r. (\u00d6rne\u011fin: Dosya t\u00fcr\u00fc olarak \u201cTam Metin\u201d se\u00e7ildiyse, dosya ad\u0131 da \u201cTam Metin\u201d olmal\u0131d\u0131r.)<\/li>\n
Tam metin dosyas\u0131 sisteme y\u00fcklenirken Word-Dosya-Bilgi k\u0131sm\u0131ndaki yazar bilgilerini kald\u0131r\u0131n\u0131z.<\/li>\n<\/ul>\n
\n
\u00d6zet ve Anahtar Kelimeler <\/strong><\/li>\n<\/ol>\n
\n
Her makalede T\u00fcrk\u00e7e ve \u0130ngilizce ba\u015fl\u0131klar ile \u00f6zet\/abstract bulunmal\u0131d\u0131r.<\/li>\n
\u00d6zetler, en fazla 250 kelime i\u00e7ermelidir.<\/li>\n
\u00d6zg\u00fcn ara\u015ft\u0131rma makalelerinde \u00f6zet b\u00f6l\u00fcm\u00fc \u015fu ba\u015fl\u0131klar\u0131 i\u00e7ermelidir:\n
\n
T\u00fcrk\u00e7e: Ama\u00e7, Gere\u00e7 ve Y\u00f6ntemler, Bulgular, Sonu\u00e7, Anahtar Kelimeler<\/li>\n
\u0130ngilizce: Objectives, Materials and Methods, Results, Conclusion, Keywords<\/li>\n<\/ul>\n<\/li>\n
Anahtar kelimeler 3-5 adet olmal\u0131, alfabetik s\u0131raya g\u00f6re dizilmeli ve MeSH (https:\/\/www.nlm.nih.gov\/mesh) ve T\u00fcrkiye Bilim Terimleri (http:\/\/www.bilimterimleri.com) listelerine uygun se\u00e7ilmelidir.<\/li>\n
Her bir anahtar kelimenin ilk kelimesinin ilk harfi b\u00fcy\u00fck olmal\u0131d\u0131r.<\/li>\n
Anahtar kelimeler virg\u00fcl ile ayr\u0131lmal\u0131d\u0131r.<\/li>\n<\/ul>\n
\n
Ba\u015fl\u0131k Sayfas\u0131 <\/strong><\/li>\n<\/ol>\n
\n
Ba\u015fl\u0131k sayfas\u0131 ayr\u0131 bir dosya olarak y\u00fcklenmelidir ve \u015fu bilgileri i\u00e7ermelidir:\n
\n
Makalenin T\u00fcrk\u00e7e ve \u0130ngilizce tam ba\u015fl\u0131\u011f\u0131 (15 kelimeyi ge\u00e7memeli) ve k\u0131sa ba\u015fl\u0131\u011f\u0131 (bo\u015fluklar dahil 50 karakteri ge\u00e7memeli).<\/li>\n
Yazar bilgileri: T\u00fcm yazarlar\u0131n ad-soyad, unvan, kurum, ORCID ID, e-posta adresleri.<\/li>\n
Sorumlu yazar\u0131n telefon numaras\u0131 ve a\u00e7\u0131k adres bilgileri.<\/li>\n
Finansal destek, \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 ve te\u015fekk\u00fcr bilgileri.<\/li>\n
Tam metin dosyas\u0131nda ge\u00e7en kurum isimlerini XXXXX olarak yaz\u0131n\u0131z ve ba\u015fl\u0131k sayfas\u0131na XXXXXX: ……… \u015feklinde ekleyiniz.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n
\n
\u015eekil ve Tablolar<\/strong><\/li>\n<\/ol>\n
\n
\u00d6zg\u00fcn ara\u015ft\u0131rmalarda tablo ve \u015fekil say\u0131s\u0131 toplam 8 adeti ge\u00e7memelidir.<\/li>\n
\u015eekil ve tablolar hem metin i\u00e7ine yerle\u015ftirilmeli hem de ayr\u0131 bir dosyada birle\u015ftirilerek sisteme y\u00fcklenmelidir.<\/li>\n
\u015eekil a\u00e7\u0131klamalar\u0131 \u015feklin alt\u0131nda, tablo a\u00e7\u0131klamalar\u0131 tablonun \u00fcst\u00fcnde yer almal\u0131d\u0131r.<\/li>\n
Tablolar ve \u015fekiller Arap rakamlar\u0131 kullan\u0131larak s\u0131ral\u0131 \u015fekilde numaraland\u0131r\u0131lmal\u0131d\u0131r (\u00f6rn. Tablo 1, \u015eekil 2).<\/li>\n
Tablolar \u00e7izgisiz bi\u00e7imde haz\u0131rlanmal\u0131, yaln\u0131zca ana ba\u015fl\u0131klar ile veriler aras\u0131nda \u00e7izgi bulunmal\u0131d\u0131r.<\/li>\n
Tablolar, \u00fcst sat\u0131r 10 punto, i\u00e7erik sat\u0131rlar\u0131 9 punto, tablo ba\u015fl\u0131\u011f\u0131 ise 8 punto olacak \u015fekilde; Times New Roman yaz\u0131 tipi ve 1.15 sat\u0131r aral\u0131\u011f\u0131yla haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<\/ul>\n
\n
Tablolar g\u00f6rsel formatlarda (\u00f6rne\u011fin JPEG, PNG) sunulmamal\u0131d\u0131r.<\/strong> Word, Excel ya da benzeri metin veya tablo d\u00fczenleyicileriyle haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<\/ul>\n
\n
\u015eekiller TIFF veya JPEG format\u0131nda, en az 300 DPI \u00e7\u00f6z\u00fcn\u00fcrl\u00fckte ve minimum 100×100 mm boyutlar\u0131nda olmal\u0131d\u0131r.<\/li>\n
\u015eekil a\u00e7\u0131klamalar\u0131, \u015fekillerin alt\u0131nda yer almal\u0131; Times New Roman yaz\u0131 tipiyle, 8 punto ve 1.15 sat\u0131r aral\u0131\u011f\u0131nda haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<\/ul>\n
\n
Kaynak\u00e7a<\/strong><\/li>\n<\/ol>\n
\n
Kaynaklar Vancouver stilinde<\/strong> d\u00fczenlenmelidir.<\/li>\n
Metin i\u00e7inde kaynaklar, \u00fcst simge (superscript) \u015feklinde, c\u00fcmle sonundaki noktalama i\u015faretinden sonra ve bo\u015fluk b\u0131rak\u0131lmadan yaz\u0131lmal\u0131d\u0131r.<\/li>\n
C\u00fcmlede yazar ad\u0131 ge\u00e7iyorsa, kaynak numaras\u0131 yazar ad\u0131n\u0131n hemen ard\u0131ndan, ilgili ifadenin sonunda, noktalama i\u015faretinden sonra \u00fcst simge olarak yaz\u0131lmal\u0131d\u0131r.\n
\n
\u00d6rn: Y\u0131lmaz\u00b9 taraf\u0131ndan yap\u0131lan \u00e7al\u0131\u015fmada bu ili\u015fki g\u00f6sterilmi\u015ftir.<\/li>\n<\/ul>\n<\/li>\n
Kaynak\u00e7a b\u00f6l\u00fcm\u00fc, \u201cKaynak\u00e7a\u201d ba\u015fl\u0131\u011f\u0131 11 punto; kaynaklar\u0131n tamam\u0131 ise 10 punto, Times New Roman yaz\u0131 tipi ve 1.15 sat\u0131r aral\u0131\u011f\u0131 ile haz\u0131rlanmal\u0131d\u0131r.<\/li>\n
Kaynak\u00e7a yaz\u0131m\u0131nda her kaynak t\u00fcr\u00fc i\u00e7in do\u011fru formatlama yap\u0131lmal\u0131 ve yaln\u0131zca metin i\u00e7inde at\u0131fta bulunulan kaynaklar listelenmelidir. PMID, PMCID, PMC gibi herhangi bir dizinin ID numaras\u0131 eklenmemelidir.<\/li>\n
Alt\u0131 veya daha az yazar varsa, t\u00fcm yazarlar listelenmelidir. Yedi veya daha fazla yazar varsa, ilk \u00fc\u00e7 yazar listelenmeli ve ard\u0131ndan referans listesinde “ve ark.” ifadesi eklenmelidir.<\/li>\n
Vancouver stiline g\u00f6re kaynak\u00e7a d\u00fczenlenirken yaln\u0131zca dergi adlar\u0131, kitap adlar\u0131 ve tez ba\u015fl\u0131klar\u0131 italik<\/strong> yaz\u0131lmal\u0131d\u0131r. Bunun d\u0131\u015f\u0131ndaki t\u00fcm bilgiler \u2014 yazar adlar\u0131, makale ba\u015fl\u0131klar\u0131, yay\u0131nevi bilgileri, sayfa numaralar\u0131 ve web sitesi adresleri dahil \u2014 normal (d\u00fcz) yaz\u0131 karakteriyle yaz\u0131lmal\u0131d\u0131r.<\/li>\n
Formatlar:<\/li>\n<\/ul>\n
6.1. Dergi Makalesi (Journal Article):<\/strong><\/p>\n
Yazar(lar). Makale ba\u015fl\u0131\u011f\u0131. Dergi Ad\u0131 (k\u0131salt\u0131lm\u0131\u015f). <\/em>Y\u0131l;Cilt(Say\u0131):Sayfa numaralar\u0131 (bo\u015fluk b\u0131rakmadan).<\/p>\n
Y\u0131lmaz B, Demirci A, Ko\u00e7ak E, ve ark. Effect of probiotic use on oral mucosa healing after dental extractions. Turk J Clin Dent.<\/em> 2023;18(2):125-32.<\/p>\n
\n
Vancouver stilinde<\/strong> sayfa numaralar\u0131nda ortak olan basamaklar tekrar edilmez<\/strong>. \u00d6rne\u011fin:<\/li>\n<\/ul>\n
151 ile 158 aras\u0131 \u2192 151-8<\/strong><\/p>\n
252 ile 261 aras\u0131 \u2192 252-61<\/strong><\/p>\n
100 ile 104 aras\u0131 \u2192 100-4<\/strong><\/p>\n
\n
Ancak iki sayfa yaln\u0131zca bir basamak fark ediyorsa, t\u00fcm say\u0131 yaz\u0131l\u0131r:<\/li>\n<\/ul>\n
198 ile 199 \u2192 198-199<\/strong><\/p>\n
6.2. Kitap B\u00f6l\u00fcm\u00fc (Book Section):<\/strong><\/p>\n
B\u00f6l\u00fcm yazar\u0131(lar\u0131). B\u00f6l\u00fcm ba\u015fl\u0131\u011f\u0131. In: Kitap edit\u00f6r\u00fc(leri), eds. Kitap Ad\u0131.<\/em> Yay\u0131n Yeri: Yay\u0131nevi; Yay\u0131n y\u0131l\u0131. s. Sayfa aral\u0131\u011f\u0131.<\/p>\n
\u00d6zt\u00fcrk M. Pediatric endodontics: current approaches. In: Y\u0131ld\u0131r\u0131m F, Ayd\u0131n B, eds. Comprehensive Pediatric Dentistry. <\/em>\u0130stanbul: Di\u015fhekimli\u011fi Yay\u0131nc\u0131l\u0131k; 2022. s. 145-158.<\/p>\n
6.3. Tek Yazarl\u0131 Kitap (Books with a Single Author):<\/strong><\/p>\n
Yazar. Kitap Ad\u0131.<\/em> Bask\u0131 say\u0131s\u0131 (varsa). Yay\u0131n Yeri: Yay\u0131nevi; Yay\u0131n y\u0131l\u0131. s. xx-yy<\/p>\n
Arens AA. Auditing in Australia: an integrated approach.<\/em> 5th ed. Frenchs Forest: Pearson Education Australia; 2002. s. xx-yy<\/p>\n
6.4. Edit\u00f6r(ler)in Yazar\u0131 Oldu\u011fu Kitap (Editor(s) as Author):<\/strong><\/p>\n
Edit\u00f6r(ler), eds. Kitap Ad\u0131.<\/em> Yay\u0131n Yeri: Yay\u0131nevi; Yay\u0131n y\u0131l\u0131. s. xx-yy<\/p>\n
Sar\u0131 E, Bozkurt M, eds. Oral and Maxillofacial Infections.<\/em> \u0130zmir: Ege T\u0131p Yay\u0131nlar\u0131; 2020. s. xx-yy<\/p>\n
6.5. Ba\u015fka Bir Dilden \u00c7evirilmi\u015f Kitap<\/strong><\/p>\n
Orijinal Yazar(lar). Kitap Ad\u0131.<\/em> \u00c7eviren: \u00c7evirmen(ler). Bask\u0131 say\u0131s\u0131 (varsa). Yay\u0131n yeri: Yay\u0131nevi; Y\u0131l. s. xx-yy<\/p>\n
Smith J. Dental Biomaterials: Principles and Applications<\/em>. \u00c7eviren: Demir A, Y\u0131ld\u0131z M. 2. bask\u0131. \u0130stanbul: Di\u015fhekimli\u011fi Yay\u0131nc\u0131l\u0131k; 2021. s. xx-yy<\/p>\n
6.6. Tez (Thesis):<\/strong><\/p>\n
Yazar. Tez ba\u015fl\u0131\u011f\u0131. <\/em>Tez t\u00fcr\u00fc. \u00dcniversite Ad\u0131; Yay\u0131n y\u0131l\u0131.<\/p>\n
Aksoy G. The Influence of Topical Fluoride Agents on Enamel Resistance in Primary Teeth.<\/em> Y\u00fcksek Lisans Tezi. Hacettepe \u00dcniversitesi; 2022.<\/p>\n
6.7. Web Siteleri (Websites):<\/strong><\/p>\n
Kurumsal veya bireysel yazar. Web sitesi ad\u0131. Eri\u015fim tarihi. URL.<\/p>\n
TDB Akademi. A\u011f\u0131z ve Di\u015f Sa\u011fl\u0131\u011f\u0131 Bilgi Portal\u0131. Eri\u015fim tarihi: 10 \u015eubat 2024. https:\/\/www.tdbakademi.org.tr<\/p>\n
6.8. Bas\u0131m \u00d6ncesi Makaleler (Epub Ahead of Print Articles):<\/strong><\/p>\n
Yazar(lar). Makale ba\u015fl\u0131\u011f\u0131. Dergi Ad\u0131.<\/em> Yay\u0131n tarihi. doi. [Epub ahead of print].<\/p>\n
Erg\u00fcn H, Temizkan A, \u00c7etin S, ve ark. Evaluation of nano-hydroxyapatite in enamel remineralization: a clinical trial. J Dent Res. <\/em>2024 Mar 5. doi: 10.1016\/j.jdentres.2024.03.007. [Epub ahead of print].<\/p>\n
\n
Etik \u0130lkeler ve Belgeler<\/strong><\/li>\n<\/ol>\n
\n
\u00d6zg\u00fcn ara\u015ft\u0131rmalar<\/strong>\u00a0i\u00e7in etik kurul onay\u0131 gereklidir. \u0130lgili onay belgesi sisteme y\u00fcklenmeli, “Gere\u00e7 ve Y\u00f6ntemler” b\u00f6l\u00fcm\u00fcnde etik kurul bilgisine yer verilmelidir.<\/li>\n
Etik kurul onay\u0131 gerektirmeyen \u00e7al\u0131\u015fmalar i\u00e7in gerek\u00e7esi belirtilmelidir.<\/li>\n
Olgu sunumlar\u0131<\/strong>\u00a0i\u00e7in ayd\u0131nlat\u0131lm\u0131\u015f onam formu ve hasta g\u00f6n\u00fcll\u00fc olur formu y\u00fcklenmelidir.<\/li>\n
Etik kurul gerekmeyen makalelerde bu durumu anlatan edit\u00f6re hitaben yaz\u0131l\u0131 bir dosya sisteme y\u00fcklenmelidir.<\/li>\n<\/ul>\n
\n
Te\u015fekk\u00fcr (Acknowledgement)<\/strong><\/li>\n<\/ol>\n
\n
Yazarl\u0131k kriterlerini kar\u015f\u0131lamayan<\/strong> ancak \u00e7al\u0131\u015fman\u0131n planlanmas\u0131, y\u00fcr\u00fct\u00fclmesi, analiz edilmesi veya raporlanmas\u0131na katk\u0131 sa\u011flayan ki\u015filer te\u015fekk\u00fcr edilerek belirtilebilir.<\/li>\n
\u00c7al\u0131\u015fmaya finansal, materyal veya teknik destek<\/strong> veren ki\u015fi, kurum veya kurulu\u015flar da bu b\u00f6l\u00fcmde yer almal\u0131d\u0131r.<\/li>\n
Destekleyici kurum veya fonlara ait varsa proje ad\u0131 ve\/veya fon numaras\u0131<\/strong> a\u00e7\u0131k\u00e7a yaz\u0131lmal\u0131d\u0131r.<\/li>\n
Te\u015fekk\u00fcr edilen ki\u015filerin, metnin i\u00e7eri\u011fini g\u00f6rd\u00fcklerine ve isimlerinin belirtilmesine onay verdikleri varsay\u0131l\u0131r<\/strong>.<\/li>\n<\/ul>\n
\u00d6rn: \u201cBu \u00e7al\u0131\u015fma, XYZ Ara\u015ft\u0131rma Fonu taraf\u0131ndan desteklenmi\u015ftir (Proje No: 12345). Yazarlar ayr\u0131ca teknik desteklerinden dolay\u0131 Dr. Ay\u015fe Kaya\u2019ya te\u015fekk\u00fcr eder.\u201d<\/p>\n
\n
Benzerlik Raporu<\/strong><\/li>\n<\/ol>\n
\n
iThenticate veya Turnitin sistemlerinden al\u0131nan benzerlik raporu ayr\u0131ca y\u00fcklenmelidir.<\/li>\n
Kabul edilen maksimum benzerlik oran\u0131 %15\u2019tir.<\/li>\n<\/ul>\n
\n
Telif Hakk\u0131 ve Di\u011fer Formlar<\/strong><\/li>\n<\/ol>\n
\n
Telif Hakk\u0131 Formu, \u00c7\u0131kar \u00c7at\u0131\u015fmas\u0131 Formu ve Yazar Katk\u0131 Formu dergi ana sayfas\u0131ndan indirilerek \u0131slak imzal\u0131 bi\u00e7imde sisteme y\u00fcklenmelidir.<\/li>\n
\u00c7\u0131kar \u00e7at\u0131\u015fmas\u0131 beyan\u0131 zorunludur. T\u00fcm yazarlar, finansal veya kurumsal ili\u015fkileri beyan etmelidir. Bu s\u00fcre\u00e7 COPE ve ICMJE rehberlerine g\u00f6re y\u00fcr\u00fct\u00fcl\u00fcr.<\/li>\n<\/ul>\n
\n
Makale T\u00fcrleri<\/strong><\/li>\n<\/ol>\n
11.1 \u00d6zg\u00fcn Ara\u015ft\u0131rma Makalesi<\/strong><\/p>\n
Klinik ve deneysel ara\u015ft\u0131rmalar bu kategoride de\u011ferlendirilir.<\/p>\n
T\u00fcrk\u00e7e: Giri\u015f, Gere\u00e7 ve Y\u00f6ntemler, Bulgular, Tart\u0131\u015fma, Sonu\u00e7.<\/p>\n
\u0130ngilizce: Introduction, Materials and Methods, Results, Discussion, Conclusion.<\/p>\n
Giri\u015f<\/em><\/strong><\/p>\n
\n
Ara\u015ft\u0131rman\u0131n konusunu, \u00f6nemini ve amac\u0131n\u0131 a\u00e7\u0131k\u00e7a ifade etmelidir.<\/li>\n
Konuyla ilgili literat\u00fcr bilgisi k\u0131sa ve \u00f6z \u015fekilde sunulmal\u0131d\u0131r.<\/li>\n
Ara\u015ft\u0131rma problemi net bir \u015fekilde tan\u0131mlanmal\u0131d\u0131r.<\/li>\n<\/ul>\n
Gere\u00e7 ve Y\u00f6ntemler<\/em><\/strong><\/p>\n
\n
Ara\u015ft\u0131rma tasar\u0131m\u0131, kullan\u0131lan materyaller ve y\u00f6ntemler ayr\u0131nt\u0131l\u0131 olarak a\u00e7\u0131klanmal\u0131d\u0131r.<\/li>\n
Kullan\u0131lan cihaz, yaz\u0131l\u0131m, kimyasal madde gibi unsurlar ticari ad\u0131 ve men\u015feiyle belirtilmelidir.<\/li>\n
\u0130statistiksel analiz y\u00f6ntemleri belirtilmelidir.<\/li>\n
Etik kurul onay\u0131 varsa etik kurulun ad\u0131, karar tarihi ve numaras\u0131 yaz\u0131lmal\u0131d\u0131r. Gerekmedi\u011fi durumlarda ise gerek\u00e7e belirtilmelidir.<\/li>\n<\/ul>\n
Bulgular<\/em><\/strong><\/p>\n
\n
Ara\u015ft\u0131rma sonu\u00e7lar\u0131 a\u00e7\u0131k ve sistematik bir \u015fekilde sunulmal\u0131d\u0131r.<\/li>\n
Gerekli durumlarda tablo ve \u015fekillerle desteklenmelidir. Tablo ve \u015fekillerle a\u00e7\u0131klanan bilgiler makalede tekrar edilmemelidir.<\/li>\n
\u0130statistiksel sonu\u00e7lar anlaml\u0131l\u0131k d\u00fczeyleriyle birlikte verilmelidir.<\/li>\n<\/ul>\n
Tart\u0131\u015fma<\/em><\/strong><\/p>\n
\n
Elde edilen bulgular literat\u00fcrle kar\u015f\u0131la\u015ft\u0131r\u0131lmal\u0131, benzerlikler ve farkl\u0131l\u0131klar de\u011ferlendirilmelidir.<\/li>\n
Bulgular\u0131n bilimsel ve klinik anlam\u0131 a\u00e7\u0131klanmal\u0131d\u0131r.<\/li>\n
Ara\u015ft\u0131rman\u0131n g\u00fc\u00e7l\u00fc ve s\u0131n\u0131rl\u0131 y\u00f6nleri belirtilmeli, gelecekteki ara\u015ft\u0131rmalar i\u00e7in \u00f6neriler sunulmal\u0131d\u0131r.<\/li>\n<\/ul>\n
Sonu\u00e7<\/em><\/strong><\/p>\n
\n
Ara\u015ft\u0131rmadan elde edilen temel sonu\u00e7lar k\u0131sa ve \u00f6z \u015fekilde ifade edilmelidir.<\/li>\n
Bulgular\u0131n tekrar\u0131ndan ka\u00e7\u0131n\u0131lmal\u0131, do\u011frudan sonu\u00e7lara odaklan\u0131lmal\u0131d\u0131r.<\/li>\n<\/ul>\n
11.2 Derleme<\/strong><\/p>\n
Di\u015f hekimli\u011fi alan\u0131ndaki g\u00fcncel konularda bilimsel literat\u00fcr \u0131\u015f\u0131\u011f\u0131nda sistematik olarak haz\u0131rlanmal\u0131, yazar(lar)\u0131n konuya dair yay\u0131n ge\u00e7mi\u015fi bulunmal\u0131d\u0131r.<\/p>\n
Giri\u015f<\/em><\/strong><\/p>\n
\n
Derlemenin konusunu ve kapsam\u0131n\u0131 tan\u0131t\u0131r.<\/li>\n
Neden bu konunun ele al\u0131nd\u0131\u011f\u0131 ve konunun g\u00fcncelli\u011fi belirtilmelidir.<\/li>\n<\/ul>\n
Alt Ba\u015fl\u0131klar<\/em><\/strong><\/p>\n
\n
Derlemenin i\u00e7eri\u011fi, yazar\u0131n uygun g\u00f6rd\u00fc\u011f\u00fc bi\u00e7imde konunun yap\u0131s\u0131na g\u00f6re alt ba\u015fl\u0131klar halinde d\u00fczenlenmelidir.<\/li>\n
Her bir alt ba\u015fl\u0131k alt\u0131nda konuyla ilgili g\u00fcncel bilgiler, yorumlar ve kar\u015f\u0131la\u015ft\u0131rmalar sunulmal\u0131d\u0131r.<\/li>\n<\/ul>\n
Sonu\u00e7<\/em><\/strong><\/p>\n
\n
Derlemede elde edilen \u00e7\u0131kar\u0131mlar \u00f6zetlenmeli, varsa \u00f6neriler sunulmal\u0131d\u0131r.<\/li>\n
Derleme metni, “Sonu\u00e7” veya “Conclusion” ba\u015fl\u0131\u011f\u0131 ile bitirilmelidir.<\/li>\n
Derleme yaz\u0131lar\u0131 \u00f6zg\u00fcn ara\u015ft\u0131rma verisi i\u00e7ermemelidir.<\/li>\n
Etik kurul onay\u0131 gerektirmeyen durumlarda bu durum gerek\u00e7esiyle birlikte belirtilmelidir.<\/li>\n
Derleme yaz\u0131lar\u0131nda yazar(lar)\u0131n konu ile ilgili bilimsel \u00e7al\u0131\u015fmalar\u0131 bulunmas\u0131 tercih sebebidir.<\/li>\n<\/ul>\n
11.3 Olgu Sunumu<\/strong><\/p>\n
Ender g\u00f6r\u00fclen, tan\u0131 ve tedavisi zor olan, literat\u00fcrde yer almayan ya da e\u011fitici de\u011feri y\u00fcksek vakalar\u0131n sunumu bu kategoride de\u011ferlendirilir.<\/p>\n
T\u00fcrk\u00e7e: Giri\u015f, Olgu Sunumu, Sonu\u00e7.<\/p>\n
\u0130ngilizce: Introduction, Case Report, Conclusion.<\/p>\n
Giri\u015f<\/em><\/strong><\/p>\n
\n
Olgunun \u00f6nemi, literat\u00fcrdeki yeri ve sunulma gerek\u00e7esi a\u00e7\u0131klanmal\u0131d\u0131r.<\/li>\n
Konuyla ilgili k\u0131sa literat\u00fcr bilgisi verilebilir.<\/li>\n<\/ul>\n
Olgu Sunumu<\/em><\/strong><\/p>\n
\n
Hastan\u0131n demografik bilgileri, ba\u015fvuru nedenleri, klinik ve radyolojik bulgular detayl\u0131 olarak a\u00e7\u0131klanmal\u0131d\u0131r.<\/li>\n
Uygulanan tedavi s\u00fcreci ad\u0131m ad\u0131m anlat\u0131lmal\u0131, varsa kullan\u0131lan malzemeler\/t\u0131bbi ara\u00e7lar belirtilmelidir.<\/li>\n
Olgu sunumlar\u0131nda hastadan\u00a0ayd\u0131nlat\u0131lm\u0131\u015f onam al\u0131nm\u0131\u015f olmal\u0131<\/strong>\u00a0ve bu durum metinde a\u00e7\u0131k\u00e7a belirtilmelidir.<\/li>\n
Kimli\u011fi belirlenebilir herhangi bir veri (g\u00f6rsel, metin) kullan\u0131lm\u0131\u015fsa etik ilkelere uygun \u015fekilde gizlilik sa\u011flanmal\u0131d\u0131r.<\/li>\n<\/ul>\n
Sonu\u00e7<\/em><\/strong><\/p>\n
\n
Vakan\u0131n de\u011ferlendirmesi, dikkat \u00e7ekici y\u00f6nleri ve literat\u00fcrle kar\u015f\u0131la\u015ft\u0131rmas\u0131 yap\u0131lmal\u0131d\u0131r.<\/li>\n
Olgunun bilimsel ve\/veya klinik katk\u0131s\u0131 vurgulanmal\u0131d\u0131r.<\/li>\n<\/ul>\n
11.4 Edit\u00f6re Mektup<\/strong><\/p>\n
Daha \u00f6nce dergide yay\u0131mlanm\u0131\u015f bir makale \u00fczerine yorum, katk\u0131, ele\u015ftiri ya da g\u00fcncel ve ilgi \u00e7ekici bilgiler sunma amac\u0131yla yaz\u0131l\u0131r. A\u015fa\u011f\u0131daki \u00f6zellikleri ta\u015f\u0131mal\u0131d\u0131r:<\/p>\n
\n
Edit\u00f6re Mektup metni\u00a0alt ba\u015fl\u0131k i\u00e7ermemeli<\/strong>\u00a0ve\u00a0\u00f6z, k\u0131sa ve anla\u015f\u0131l\u0131r<\/strong>\u00a0olmal\u0131d\u0131r.<\/li>\n
\u0130lgili makaleye a\u00e7\u0131k at\u0131f yap\u0131lmal\u0131d\u0131r; makalenin\u00a0ba\u015fl\u0131\u011f\u0131, yazarlar\u0131, cilt, y\u0131l, say\u0131 ve sayfa numaralar\u0131<\/strong>\u00a0belirtilmelidir.<\/li>\n
Makale hakk\u0131nda yap\u0131lan at\u0131flar metin i\u00e7inde a\u00e7\u0131k\u00e7a g\u00f6sterilmeli ve kaynak listesine dahil edilmelidir.<\/li>\n
\u00d6zet, anahtar kelime, tablo, \u015fekil, resim ve di\u011fer g\u00f6rseller kullan\u0131lmamal\u0131d\u0131r.<\/li>\n<\/ul>\n
Mektup, bir sayfay\u0131 a\u015fmamal\u0131 ve yaln\u0131zca derginin kapsam\u0131na uygun konular i\u00e7ermelidir.<\/p>\n
12. \u0130nceleme S\u00fcreci<\/strong>
\n\u2022 Dergimize g\u00f6nderilen t\u00fcm makaleler \u00f6ncelikle edit\u00f6rler taraf\u0131ndan\u00a0\u00f6n de\u011ferlendirmeye<\/strong>\u00a0al\u0131n\u0131r.
\n\u2022 Edit\u00f6rl\u00fck, bilimsel niteli\u011fi ve etik uygunlu\u011fu yeterli g\u00f6r\u00fclmeyen \u00e7al\u0131\u015fmalar\u0131 de\u011ferlendirmeye almama hakk\u0131n\u0131 sakl\u0131 tutar.
\n\u2022 Bi\u00e7imsel ve etik uygunlu\u011fu sa\u011flanan \u00e7al\u0131\u015fmalar, konu alan\u0131na g\u00f6re uzman en az\u00a0iki hakeme<\/strong>\u00a0g\u00f6nderilir.
\n\u2022 Hakem de\u011ferlendirmesi\u00a0\u00e7ift k\u00f6r (double-blind)<\/strong>\u00a0sistemle y\u00fcr\u00fct\u00fcl\u00fcr. Yani yazar ve hakemler birbirlerinin kimli\u011fini bilmez.
\n\u2022 Hakemlerden gelen g\u00f6r\u00fc\u015fler do\u011frultusunda edit\u00f6r a\u015fa\u011f\u0131daki kararlardan birini verir:
\no Yay\u0131nlanabilir
\no D\u00fczeltme ile yeniden g\u00f6nderilmeli
\no Red
\n\u2022 Yazarlar, d\u00fczeltme taleplerini i\u00e7eren hakem yorumlar\u0131na belirli s\u00fcre i\u00e7inde yan\u0131t vermelidir. Her revizyon, gerekirse tekrar hakemlere g\u00f6nderilebilir.<\/p>\n
13. Revizyon S\u00fcreci<\/strong><\/p>\n
Revizyon karar\u0131 verilen durumlarda, yazarlar\u00a0hakemlerin t\u00fcm yorumlar\u0131n\u0131 tek tek yan\u0131tlad\u0131klar\u0131<\/strong>\u00a0bir dosya haz\u0131rlamal\u0131 ve bu dosyay\u0131\u00a0\u201cHakeme Yan\u0131t\u201d<\/strong>\u00a0ad\u0131yla\u00a0ayr\u0131 bir Word belgesi<\/strong>\u00a0olarak sisteme y\u00fcklemelidir.<\/p>\n
Yan\u0131t haz\u0131rlan\u0131rken:<\/p>\n
\u2022 Her ele\u015ftiriye kar\u015f\u0131l\u0131k verilen metin k\u0131sm\u0131n\u0131n sat\u0131r numaras\u0131 mutlaka belirtilmelidir.
\n\u2022 Ana metinde yap\u0131lan de\u011fi\u015fiklikler,\u00a0metin vurgusu (highlight)<\/strong>\u00a0kullan\u0131larak i\u015faretlenmelidir.<\/p>\n
\u00d6rnek:<\/strong>
\nHakem, kullan\u0131lan materyalin men\u015feinin belirtilmedi\u011fine dair bir ele\u015ftiri yapm\u0131\u015fsa;
\n\u201cMetnin 56. sat\u0131r\u0131nda, kullan\u0131lan materyalin men\u015fei parantez i\u00e7inde eklenmi\u015ftir.\u201d \u015feklinde yan\u0131t verilmelidir.
\nRevize edilen ana metinde ise ilgili d\u00fczeltme \u015fu \u015fekilde vurgulanmal\u0131d\u0131r:
\n\u201cMTA\u00a0(Pro Root, Dentsply\/Tulsa Dental, Tulsa OK)<\/strong>\u00a0kullan\u0131larak i\u00e7 rezorpsiyonun tedavi edilmesine karar verilmi\u015ftir.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
Makale Dili ve Bi\u00e7imsel \u00d6zellikler Makaleler T\u00fcrk\u00e7e veya \u0130ngilizce dillerinde kabul edilmektedir. Sayfa yap\u0131s\u0131: T\u00fcm kenarlardan…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/pages\/228"}],"collection":[{"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/comments?post=228"}],"version-history":[{"count":32,"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/pages\/228\/revisions"}],"predecessor-version":[{"id":1627,"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/pages\/228\/revisions\/1627"}],"wp:attachment":[{"href":"https:\/\/aydindental.aydin.edu.tr\/tr\/wp-json\/wp\/v2\/media?parent=228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}